Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1997 | 03-1997 | 12-1996 | 09-1996 | 06-1996 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,671 | 12,242 | N/A | 14,363 | 6,727 |
| Receivables | 18 | 19 | N/A | 16 | 10 |
| Inventories | N/A | 22 | 20 | 7 | 15 |
| Other current assets | 274 | 286 | 640 | 731 | 668 |
| TOTAL | $10,963 | $12,570 | $660 | $15,117 | $7,420 |
| Non-Current Assets | |||||
| PPE Net | 3,083 | 3,073 | N/A | 2,917 | 2,902 |
| Other Non-Current Assets | 0 | 0 | 3,430 | 3,675 | 3,812 |
| TOTAL | $3,083 | $3,073 | $3,430 | $6,592 | $6,714 |
| Total Assets | $13,385 | $15,045 | $4,090 | $19,257 | $11,745 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 320 | 122 | 177 |
| Accrued Expenses | N/A | N/A | 1,270 | 978 | 1,205 |
| TOTAL | $1,380 | $1,359 | $1,590 | $1,100 | $1,382 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 181 | 182 |
| TOTAL | $N/A | $N/A | $N/A | $181 | $182 |
| Total Liabilities | $1,380 | $1,359 | $1,590 | $1,281 | $1,564 |
| Shareholders' Equity | |||||
| Common Shares | 25 | 25 | 20 | 26 | 20 |
| Retained earnings | N/A | N/A | N/A | -54,773 | -52,498 |
| Other shareholders' equity | 11,980 | 13,661 | -60 | -69 | -69 |
| TOTAL | $12,005 | $13,686 | $72,750 | $17,976 | $10,181 |
| Total Liabilities And Equity | $13,385 | $15,045 | $74,340 | $19,257 | $11,745 |